(Total Views: 87)
Posted On: 10/12/2022 11:35:50 AM
Post# of 47159

$INVA News Article - Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR to be Presented at IDWeek 2022 https://marketwirenews.com/news-releases/enta...02917.html


My Twitter: WhyteStocks